Hoffman B B, Tsujimoto G
Clin Sci (Lond). 1985;68 Suppl 10:35s-37s. doi: 10.1042/cs068s035.
alpha-Adrenoceptors play an important role in regulating vascular tone. [125I]BE2254, a high affinity antagonist, has been utilized to label alpha 1-receptors in membrane preparations from rabbit aorta. [125I]BE2254 specifically labels a single class of binding sites with the characteristics of alpha 1-receptors. Catecholamines compete for [125I]BE2254 binding stereospecifically and with the characteristic alpha-adrenergic potency series (-)-adrenaline greater than or equal to (-)-noradrenaline much greater than (-)-isoprenaline. The alpha 1-adrenoceptor selective antagonist prazosin is much more potent than yohimbine in competing for the [125I]BE2254 binding sites, which suggests that the alpha-adrenoceptor identified is predominantly of the alpha 1 subtype. The extension of radioligand binding techniques to individual rabbit aortas should simplify the study of vascular alpha-adrenoceptor regulation.
α-肾上腺素能受体在调节血管张力方面发挥着重要作用。[125I]BE2254是一种高亲和力拮抗剂,已被用于标记兔主动脉膜制剂中的α1受体。[125I]BE2254特异性标记一类具有α1受体特征的结合位点。儿茶酚胺以立体特异性方式竞争[125I]BE2254结合,且具有特征性的α-肾上腺素能效价序列(-)-肾上腺素≥(-)-去甲肾上腺素>>(-)-异丙肾上腺素。α1-肾上腺素能受体选择性拮抗剂哌唑嗪在竞争[125I]BE2254结合位点方面比育亨宾更有效,这表明所鉴定的α-肾上腺素能受体主要是α1亚型。将放射性配体结合技术应用于单个兔主动脉应会简化对血管α-肾上腺素能受体调节的研究。